Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO | 0 | reported | 01 Oct 2011 | tx 28+62,440.86−60,351 |
| Ovid Therapeutics Inc. | 0 | reported | 23 Mar 2026 | tx 29+7,534,162−2,094,681 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | EXERCISE | Ovid Therapeutics Inc. | 47,333 | 1.40 USD | |
| 23 Mar 2026 | EXERCISE | Ovid Therapeutics Inc. | 47,333 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Ovid Therapeutics Inc. | 957,000 | 0.00 USD | deriv |
| 15 Dec 2025 | CONVERSION | Ovid Therapeutics Inc. | 71,000 | — | |
| 15 Dec 2025 | CONVERSION | Ovid Therapeutics Inc. | 71 | 0.00 USD | deriv |
| 11 Dec 2025 | PURCHASE | Ovid Therapeutics Inc. | 47,333 | — | deriv |
| 11 Dec 2025 | PURCHASE | Ovid Therapeutics Inc. | 71 | — | deriv |
| 11 Dec 2025 | PURCHASE | Ovid Therapeutics Inc. | 35,500 | — | derivfirst after silence |
| 20 Feb 2025 | GRANT_AWARD | Ovid Therapeutics Inc. | 1,650,000 | 0.00 USD | deriv |
| 18 Mar 2024 | PURCHASE | Ovid Therapeutics Inc. | 18,248 | 2.76 USD | first after silence |
| 22 Feb 2024 | GRANT_AWARD | Ovid Therapeutics Inc. | 700,000 | 0.00 USD | deriv |
| 04 Dec 2023 | GIFT | Ovid Therapeutics Inc. | 573,275 | 0.00 USD | |
| 04 Dec 2023 | GIFT | Ovid Therapeutics Inc. | 573,275 | 0.00 USD | |
| 23 Feb 2023 | GRANT_AWARD | Ovid Therapeutics Inc. | 600,000 | 0.00 USD | deriv |
| 08 Apr 2022 | GRANT_AWARD | Ovid Therapeutics Inc. | 423,244 | 0.00 USD | deriv |
| 03 Feb 2022 | GRANT_AWARD | Ovid Therapeutics Inc. | 600,000 | 0.00 USD | deriv |
| 17 Dec 2020 | GRANT_AWARD | Ovid Therapeutics Inc. | 650,000 | 0.00 USD | deriv |
| 28 Aug 2020 | PURCHASE | Ovid Therapeutics Inc. | 8,488 | 5.84 USD | |
| 18 Dec 2019 | GRANT_AWARD | Ovid Therapeutics Inc. | 600,000 | 0.00 USD | deriv |
| 08 Oct 2019 | PURCHASE | Ovid Therapeutics Inc. | 60,000 | 2.50 USD | |
| 22 Feb 2019 | PURCHASE | Ovid Therapeutics Inc. | 75,000 | 2.00 USD | first after silence |
| 24 Feb 2019 | GRANT_AWARD | Ovid Therapeutics Inc. | 250,000 | 0.00 USD | deriv |
| 19 Jan 2018 | GRANT_AWARD | Ovid Therapeutics Inc. | 290,000 | 0.00 USD | deriv |
| 25 Aug 2017 | PURCHASE | Ovid Therapeutics Inc. | 15,334 | 7.15 USD | |
| 10 May 2017 | CONVERSION | Ovid Therapeutics Inc. | 400,150 | — |
3 purchases reported after at least 12 months of silence — most recent on 11 Dec 2025.